Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19
Clinical trial NCT05886816 · RECRUITING
Trial details
- NCT number
- NCT05886816
- Sponsor
- University of Texas Southwestern Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2026-07-31
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.